Filings for Rule Number 4729:9-1-01.2

Title Isotonitazene.
Agency State Board of Pharmacy
Division Controlled Substances and Drugs of Concern
Contact Cameron McNamee
Phone 614-466-7322

Actions

Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
No Current Actions
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
Nitazene compounds. 06/04/2024 Emergency New 119.03 06/04/2024 12/01/2024 N
Rule Body
Benzimidazole-opioids. 04/06/2022 Emergency New 119.03 04/06/2022 10/04/2022 N
Rule Body
Isotonitazene. 05/22/2020 Emergency New 119.03 05/22/2020 11/19/2020 N
Rule Body
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Nitazene compounds. 06/04/2024 Emergency New 119.03 06/04/2024 12/01/2024 N
Benzimidazole-opioids. 04/06/2022 Emergency New 119.03 04/06/2022 10/04/2022 N
Isotonitazene. 05/22/2020 Emergency New 119.03 05/22/2020 11/19/2020 N